SERS and MD simulation studies of a kinase inhibitor demonstrate the emergence of a potential drug discovery tool. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

SERS and MD simulation studies of a kinase inhibitor demonstrate the emergence of a potential drug discovery tool.

Karthigeyan D, Siddhanta S, Kishore AH, Perumal SS, ?gren H, Sudevan S, Bhat AV, Balasubramanyam K, Subbegowda RK, Kundu TK, Narayana C. SERS and MD simulation studies of a kinase inhibitor demonstrate the emergence of a potential drug discovery tool. Proc Natl Acad Sci U S A. 2014 Jul 22; 111(29):10416-21.

View in: PubMed

authors with profiles

Balasubramanyam Karanam

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support